Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Shares Outstanding (Weighted Average): 2014-2020

Historic Shares Outstanding (Weighted Average) for Larimar Therapeutics (LRMR) over the last 7 years, with Dec 2020 value amounting to $15.4 million.

  • Larimar Therapeutics' Shares Outstanding (Weighted Average) rose 393.05% to $15.4 million in Q4 2020 from the same period last year, while for Sep 2020 it was $15.4 million, marking a year-over-year increase of 393.10%. This contributed to the annual value of $63.8 million for FY2024, which is 45.33% up from last year.
  • As of Q4 2020, Larimar Therapeutics' Shares Outstanding (Weighted Average) stood at $15.4 million, which was down 0.00% from $15.4 million recorded in Q3 2020.
  • In the past 5 years, Larimar Therapeutics' Shares Outstanding (Weighted Average) ranged from a high of $15.4 million in Q3 2020 and a low of $2.3 million during Q1 2016.
  • In the last 3 years, Larimar Therapeutics' Shares Outstanding (Weighted Average) had a median value of $3.1 million in 2019 and averaged $5.0 million.
  • Data for Larimar Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY soared of 393.10% (in 2020) over the last 5 years.
  • Quarterly analysis of 5 years shows Larimar Therapeutics' Shares Outstanding (Weighted Average) stood at $2.3 million in 2016, then rose by 0.57% to $2.3 million in 2017, then spiked by 34.13% to $3.1 million in 2018, then rose by 1.37% to $3.1 million in 2019, then skyrocketed by 393.05% to $15.4 million in 2020.
  • Its Shares Outstanding (Weighted Average) stands at $15.4 million for Q4 2020, versus $15.4 million for Q3 2020 and $3.1 million for Q2 2020.